» Articles » PMID: 19041781

Non-cell-autonomous Effect of Human SOD1 G37R Astrocytes on Motor Neurons Derived from Human Embryonic Stem Cells

Overview
Journal Cell Stem Cell
Publisher Cell Press
Specialty Cell Biology
Date 2008 Dec 2
PMID 19041781
Citations 253
Authors
Affiliations
Soon will be listed here.
Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron death. ALS can be induced by mutations in the superoxide dismutase 1 gene (SOD1). Evidence for the non-cell-autonomous nature of ALS emerged from the observation that wild-type glial cells extended the survival of SOD1 mutant motor neurons in chimeric mice. To uncover the contribution of astrocytes to human motor neuron degeneration, we cocultured hESC-derived motor neurons with human primary astrocytes expressing mutated SOD1. We detected a selective motor neuron toxicity that was correlated with increased inflammatory response in SOD1-mutated astrocytes. Furthermore, we present evidence that astrocytes can activate NOX2 to produce superoxide and that effect can be reversed by antioxidants. We show that NOX2 inhibitor, apocynin, can prevent the loss of motor neurons caused by SOD1-mutated astrocytes. These results provide an assay for drug screening using a human ALS in vitro astrocyte-based cell model.

Citing Articles

Modeling ALS with Patient-Derived iPSCs: Recent Advances and Future Potentials.

Dawoody Nejad L, Pioro E Brain Sci. 2025; 15(2).

PMID: 40002468 PMC: 11852857. DOI: 10.3390/brainsci15020134.


Herbal Medicine Extracts Improve Motor Function by Anti-Inflammatory Activity in hSOD1 Animal Model.

Yang E, Lee S Mediators Inflamm. 2025; 2025:1999953.

PMID: 39981400 PMC: 11842138. DOI: 10.1155/mi/1999953.


Astrocyte-Mediated Neuroinflammation in Neurological Conditions.

Zhao Y, Huang Y, Cao Y, Yang J Biomolecules. 2024; 14(10).

PMID: 39456137 PMC: 11505625. DOI: 10.3390/biom14101204.


Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death.

Martinez P, Silva M, Abarzua S, Tevy M, Jaimovich E, Constantine-Paton M Mol Med. 2024; 30(1):185.

PMID: 39455931 PMC: 11505737. DOI: 10.1186/s10020-024-00942-4.


Combination AAV therapy with galectin-1 and SOD1 downregulation demonstrates superior therapeutic effect in a severe ALS mouse model.

Baird M, Likhite S, Vetter T, Caporale J, Girard H, Roussel F Mol Ther Methods Clin Dev. 2024; 32(3):101312.

PMID: 39257530 PMC: 11385756. DOI: 10.1016/j.omtm.2024.101312.